Clinicopathologic and cytogenetic analysis of malignant rhabdoid tumor of the central nervous system
Robert P. Hasserjian(Massachusetts General Hospital), Deborah E. Schofield(University of Southern California), Rebecca D. Folkerth(Allen Institute for Brain Science), R. Michael Scott(Boston Children's Hospital)
Cited by 23
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy
|Acta Neuropathologica|2015|899
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
Microvascular Injury in the Brains of Patients with Covid-19
|New England Journal of Medicine|2020|603